Itacitinib for the Prevention of Graft Versus Host Disease
Itacitinib for the Prevention of Graft Versus Host Disease
Active, not recruiting · NCT04859946 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Itacitinib for the Prevention of Graft Versus Host Disease | Hemic and Lymphatic Diseases, hematologic disorder | Active, not recruiting | Phase 2 | 2026-10-07 | NCT04859946 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Incyte Corporation | 153 |
| M.D. Anderson Cancer Center | 1145 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| M D Anderson Cancer Center | Houston | United States | 667 |